2015
DOI: 10.1515/pjs-2015-0079
|View full text |Cite
|
Sign up to set email alerts
|

Randomized Clinical Trial To Compare The Effects Of Preoperative Oral Carbohydrate Loading Versus Placebo On Insulin Resistance And Cortisol Level After Laparoscopic Cholecystectomy*

Abstract: We believe that CHO-loading is not clinically justified in case of laparoscopic cholecystectomy. No effect on the levels of glucose, insulin resistance and cortisol was observed. Even though such procedure is safe, in our opinion there is no clinical benefit from CHO-loading prior to laparoscopic cholecystectomy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
36
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 20 publications
(37 citation statements)
references
References 26 publications
0
36
1
Order By: Relevance
“…Levels two and three represent those with mild or severe systemic disease. Of the studies assessed, eleven included patients with an ASA grade of I‐II (Bisgaard et al, ; Faria et al, ; Hausel et al, ; Hausel, Nygren, Thorell, Lagerkranser, & Ljungqvist, ; Kaška et al, ; Noblett et al, ; Pexe‐Machado, Oliveira, Dock‐Nascimento, & Aguilar‐Nascimento, ; Sada et al, ; Yagmurdur, Gunal, Yildiz, Gulec, & Topkaya, ; Yildiz, Gunal, Yilmaz, & Yucel, ; Yilmaz et al, ), five studies included patients with ASA grade of I‐III (Mathur et al, ; Pędziwiatr et al, ; Savluk et al, ; Wang, Wang, Wang, & Qin, ; Yang, Yan‐Bing, Xue‐Long, Dong, & Zhi‐Hao, ), and six trials did not state the patients’ ASA grade (Järvelä, Maaranen, & Sisto, ; Lidder et al, ; Rapp‐Kesek, Stridsberg, Andersson, Berne, & Karlsson, ; Singh et al, ; Webster et al, ; Yuill, Richardson, Davidson, Garden, & Parks, ).…”
Section: Resultsmentioning
confidence: 99%
See 4 more Smart Citations
“…Levels two and three represent those with mild or severe systemic disease. Of the studies assessed, eleven included patients with an ASA grade of I‐II (Bisgaard et al, ; Faria et al, ; Hausel et al, ; Hausel, Nygren, Thorell, Lagerkranser, & Ljungqvist, ; Kaška et al, ; Noblett et al, ; Pexe‐Machado, Oliveira, Dock‐Nascimento, & Aguilar‐Nascimento, ; Sada et al, ; Yagmurdur, Gunal, Yildiz, Gulec, & Topkaya, ; Yildiz, Gunal, Yilmaz, & Yucel, ; Yilmaz et al, ), five studies included patients with ASA grade of I‐III (Mathur et al, ; Pędziwiatr et al, ; Savluk et al, ; Wang, Wang, Wang, & Qin, ; Yang, Yan‐Bing, Xue‐Long, Dong, & Zhi‐Hao, ), and six trials did not state the patients’ ASA grade (Järvelä, Maaranen, & Sisto, ; Lidder et al, ; Rapp‐Kesek, Stridsberg, Andersson, Berne, & Karlsson, ; Singh et al, ; Webster et al, ; Yuill, Richardson, Davidson, Garden, & Parks, ).…”
Section: Resultsmentioning
confidence: 99%
“…The 22 trials included in this review were conducted across 13 different countries: four in Turkey (Savluk et al, ; Yagmurdur et al, ; Yildiz et al, ; Yilmaz et al, ), two in Brazil (Faria et al, ; Pexe‐Machado et al, ), three in the UK (Lidder et al, ; Noblett et al, ; Yuill et al, ), three in Sweden (Hausel et al, ; Hausel et al, ; Rapp‐Kesek et al, ), two in China (Wang et al, ; Yang et al, ) and one each in Poland (Pędziwiatr et al, ), Australia (Webster et al, ), Denmark (Bisgaard et al, ), New Zealand (Mathur et al, ), Kosovo/Serbia (Sada et al, ), Czech republic (Kaška et al, ), India (Singh et al, ) and Finland (Järvelä et al, ).…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations